Your search returned 6 results.

Results
	1.	Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis: a prospective nonblinded randomized study using endoscopic stents. [electronic resource] by Jacob, L Geenen, J E Catalano, M F Geenen, D J Producer: 20011205 In: Endoscopy vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Clinical presentation and short-term outcome of endoscopic therapy of patients with symptomatic incomplete pancreas divisum. [electronic resource] by Jacob, L Geenen, J E Catalano, M F Johnson, G K Geenen, D J Hogan, W J Producer: 19990219 In: Gastrointestinal endoscopy vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. [electronic resource] by Talley, N J Verlinden, M Geenen, D J Hogan, R B Riff, D McCallum, R W Mack, R J Producer: 20010920 In: Gut vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Endoscopic therapy for benign bile duct strictures. [electronic resource] by Geenen, D J Geenen, J E Hogan, W J Schenck, J Venu, R P Johnson, G K Jackson, A Producer: 19891117 In: Gastrointestinal endoscopy vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The role of surveillance endoscopic retrograde cholangiopancreatography in preventing episodic cholangitis in patients with recurrent common bile duct stones. [electronic resource] by Geenen, D J Geenen, J E Jafri, F M Hogan, W J Catalano, M F Johnson, G K Schmalz, M J Producer: 19980520 In: Endoscopy vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. [electronic resource] by Van Assche, G Sandborn, W J Feagan, B G Salzberg, B A Silvers, D Monroe, P S Pandak, W M Anderson, F H Valentine, J F Wild, G E Geenen, D J Sprague, R Targan, S R Rutgeerts, P Vexler, V Young, D Shames, R S Producer: 20061114 In: Gut vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)